| pubmed-article:20149473 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20149473 | lifeskim:mentions | umls-concept:C0920317 | lld:lifeskim |
| pubmed-article:20149473 | lifeskim:mentions | umls-concept:C0007097 | lld:lifeskim |
| pubmed-article:20149473 | lifeskim:mentions | umls-concept:C1533685 | lld:lifeskim |
| pubmed-article:20149473 | lifeskim:mentions | umls-concept:C0000983 | lld:lifeskim |
| pubmed-article:20149473 | lifeskim:mentions | umls-concept:C0001962 | lld:lifeskim |
| pubmed-article:20149473 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:20149473 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
| pubmed-article:20149473 | lifeskim:mentions | umls-concept:C0850292 | lld:lifeskim |
| pubmed-article:20149473 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:20149473 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:20149473 | pubmed:dateCreated | 2010-3-2 | lld:pubmed |
| pubmed-article:20149473 | pubmed:abstractText | Radiofrequency ablation (RFA) is often the preferred local ablation therapy for hepatocellular carcinoma (HCC). Percutaneous ethanol injection (PEI) is less frequently used, and percutaneous acetic acid injection (PAI) has been mostly abandoned. Robust evidence showing benefit of one therapy versus another is lacking. Our aim was to evaluate the evidence comparing RFA, PEI and PAI using meta-analytical techniques. | lld:pubmed |
| pubmed-article:20149473 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20149473 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20149473 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20149473 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20149473 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20149473 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20149473 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20149473 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:20149473 | pubmed:issn | 0168-8278 | lld:pubmed |
| pubmed-article:20149473 | pubmed:author | pubmed-author:MeyerTimT | lld:pubmed |
| pubmed-article:20149473 | pubmed:author | pubmed-author:BurroughsAndr... | lld:pubmed |
| pubmed-article:20149473 | pubmed:author | pubmed-author:GurusamyKurin... | lld:pubmed |
| pubmed-article:20149473 | pubmed:author | pubmed-author:GermaniGiacom... | lld:pubmed |
| pubmed-article:20149473 | pubmed:author | pubmed-author:PleguezueloMa... | lld:pubmed |
| pubmed-article:20149473 | pubmed:author | pubmed-author:IsgròGraziell... | lld:pubmed |
| pubmed-article:20149473 | pubmed:copyrightInfo | Copyright (c) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. | lld:pubmed |
| pubmed-article:20149473 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20149473 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:20149473 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20149473 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20149473 | pubmed:pagination | 380-8 | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:meshHeading | pubmed-meshheading:20149473... | lld:pubmed |
| pubmed-article:20149473 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20149473 | pubmed:articleTitle | Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. | lld:pubmed |
| pubmed-article:20149473 | pubmed:affiliation | The Royal Free Sheila Sherlock Liver Centre and University Department of Surgery, Royal Free Hospital, Pond Street, London, UK. | lld:pubmed |
| pubmed-article:20149473 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20149473 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:20149473 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20149473 | lld:pubmed |
